[go: up one dir, main page]

EA199800133A1 - Способ получения композиции поперечно-сшитого биологического полисахаридного геля, композиция и её применение - Google Patents

Способ получения композиции поперечно-сшитого биологического полисахаридного геля, композиция и её применение

Info

Publication number
EA199800133A1
EA199800133A1 EA199800133A EA199800133A EA199800133A1 EA 199800133 A1 EA199800133 A1 EA 199800133A1 EA 199800133 A EA199800133 A EA 199800133A EA 199800133 A EA199800133 A EA 199800133A EA 199800133 A1 EA199800133 A1 EA 199800133A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cross
polysaccharide
gel composition
linking
linked
Prior art date
Application number
EA199800133A
Other languages
English (en)
Other versions
EA001500B1 (ru
Inventor
Бенгт Огеруп
Original Assignee
К Мед Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24001615&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199800133(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by К Мед Аб filed Critical К Мед Аб
Publication of EA199800133A1 publication Critical patent/EA199800133A1/ru
Publication of EA001500B1 publication Critical patent/EA001500B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Colloid Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Настоящее изобретение указывает способ получения композиции поперечно сшитого биологически совместимого полисахаридного геля, который включает образование водного раствора растворимого в воде поперечно сшиваемого полисахарида; инициирование поперечного сшивания указанного полисахарида в присутствии полифункционального агента для его поперечного сшивания; стерическое затруднение реакции поперечного сшивания до ее завершения перед осуществлением гелеобразования, при этом получают активированный полисахарид; и повторное введение стерически не затрудненных условий для указанного активированного полисахарида так, чтобы продолжить его поперечное сшивание до вязкоупругого геля. Изобретение также указывает композицию геля, получаемую с помощью такого способа, а также композиции геля для различных медицинских применений.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800133A 1995-07-17 1996-05-28 Способ получения композиции поперечно-сшитого биологически совместимого полисахаридного геля, композиции указанного геля и применение композиций EA001500B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/503,323 US5827937A (en) 1995-07-17 1995-07-17 Polysaccharide gel composition
PCT/SE1996/000684 WO1997004012A1 (en) 1995-07-17 1996-05-28 Polysaccharide gel composition

Publications (2)

Publication Number Publication Date
EA199800133A1 true EA199800133A1 (ru) 1998-10-29
EA001500B1 EA001500B1 (ru) 2001-04-23

Family

ID=24001615

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800133A EA001500B1 (ru) 1995-07-17 1996-05-28 Способ получения композиции поперечно-сшитого биологически совместимого полисахаридного геля, композиции указанного геля и применение композиций

Country Status (25)

Country Link
US (1) US5827937A (ru)
EP (1) EP0839159B1 (ru)
JP (1) JP3094074B2 (ru)
KR (1) KR100314488B1 (ru)
CN (1) CN1083849C (ru)
AT (1) ATE204000T1 (ru)
BR (2) BR9609534B1 (ru)
CA (1) CA2226488C (ru)
CZ (1) CZ290755B6 (ru)
DE (2) DE69614391T2 (ru)
DK (1) DK0839159T3 (ru)
EA (1) EA001500B1 (ru)
ES (1) ES2161368T3 (ru)
GR (1) GR3037065T3 (ru)
HU (1) HU220257B (ru)
MX (1) MX9800484A (ru)
NO (1) NO315274B1 (ru)
NZ (1) NZ312229A (ru)
PL (1) PL188071B1 (ru)
PT (1) PT839159E (ru)
SI (1) SI0839159T1 (ru)
SK (1) SK282431B6 (ru)
TR (1) TR199800072T1 (ru)
UA (1) UA48980C2 (ru)
WO (1) WO1997004012A1 (ru)

Families Citing this family (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
US7060287B1 (en) 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
JP3263399B2 (ja) * 1996-05-23 2002-03-04 サムヤン コーポレーション 局所投与型生分解性徐放型歯周炎用薬剤組成物及びその製造方法
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
US7192984B2 (en) * 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
US6495608B1 (en) 1997-07-29 2002-12-17 Alcon Manufacturing, Ltd. Methods of performing surgery with galactomannan polymers and borate
GB9902412D0 (en) 1999-02-03 1999-03-24 Fermentech Med Ltd Process
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
US8188043B2 (en) * 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
KR100721752B1 (ko) 2000-01-24 2007-05-25 쿠라레 메디카루 가부시키가이샤 수팽윤성 고분자 겔 및 그 제조법
SE0004928D0 (sv) * 2000-12-29 2000-12-29 Apbiotech Ab A method for the manufacturing of porous material
FR2819722B1 (fr) * 2001-01-19 2006-11-24 Corneal Ind Utilisation de l'acide hyaluronique ou d'au moins l'un de ses sels dans le cadre d'un traitemnet chirurgical de la presbytie
US8580290B2 (en) * 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
US20070078435A1 (en) * 2001-06-14 2007-04-05 Corbett Stone Tissue augmentation methods using a medical injection apparatus
ATE374796T1 (de) * 2001-12-11 2007-10-15 Ceapro Inc Zusammensetzungen auf der basis von beta glukan aus getreiden, verfahren zur herstellung und verwendungen
KR20040009891A (ko) * 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
WO2004046200A1 (ja) * 2002-11-21 2004-06-03 Chugai Seiyaku Kabushiki Kaisha 薬物徐放担体
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AU2003901834A0 (en) 2003-04-17 2003-05-01 Clearcoll Pty Ltd Cross-linked polysaccharide compositions
JP2004323454A (ja) * 2003-04-25 2004-11-18 Chisso Corp 薬剤
AU2004261752B2 (en) * 2003-07-30 2010-10-28 Anteis S.A. Complex matrix for biomedical use
US8137685B2 (en) 2003-10-29 2012-03-20 Teijin Limited Hyaluronic acid compound, hydrogel thereof and joint treating material
WO2005054301A1 (ja) * 2003-11-14 2005-06-16 Chugai Seiyaku Kabushiki Kaisha 架橋多糖微粒子およびその製造方法
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
US20050226936A1 (en) * 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
SE0401182D0 (sv) * 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
ES2609105T3 (es) 2004-05-20 2017-04-18 Mentor Worldwide Llc Método de enlance covalente de ácido hialurónico y quitosano
FR2871692B1 (fr) * 2004-06-22 2007-08-03 Epitact Md Sa Procede et dispositif pour accelerer la croissance des phaneres, notamment des ongles
TW200612991A (en) 2004-09-07 2006-05-01 Chugai Pharmaceutical Co Ltd Process for producing water-soluble hyaluronic acid modification
EP1818344A4 (en) * 2004-11-15 2012-04-18 Shiseido Co Ltd METHOD FOR SYNTHESIZING RETICULATED HYALURONIC ACID GEL
US20060105022A1 (en) * 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
KR20140041926A (ko) 2004-12-30 2014-04-04 젠자임 코포레이션 관절내 관절액보충요법을 위한 치료 방법
WO2006121803A1 (en) 2005-05-05 2006-11-16 Sensient Flavors Inc. Production of beta-glucans and mannans
CA2610592A1 (en) * 2005-06-16 2006-12-28 Artes Medical, Inc. Liquid crystal polymer syringes and containers and methods of use for long term storage of filler materials
KR101250846B1 (ko) * 2005-07-04 2013-04-05 주식회사 엘지생명과학 히알루론산 가교물의 제조방법
US20070102010A1 (en) * 2005-10-07 2007-05-10 Lemperle Stefan M Naso-pharyngeal tissue engineering
CN100379763C (zh) * 2006-01-12 2008-04-09 武汉大学 交联茯苓多糖及其制备方法和用途
US20070184087A1 (en) 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
DE102006013594A1 (de) * 2006-03-22 2007-09-27 Biopolymer Gmbh & Co. Kg Quervernetzte Gele von Hyaluronsäure und deren Verwendung
EP2543340A1 (en) * 2006-05-19 2013-01-09 Trustees Of Boston University Novel hydrophilic polymers as medical lubricants and gels
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
JP5443976B2 (ja) * 2007-05-01 2014-03-19 国立大学法人 東京医科歯科大学 化学架橋ヒアルロン酸誘導体を含むハイブリッドゲルおよびそれを用いた医薬組成物
WO2008143680A1 (en) * 2007-05-16 2008-11-27 Medicis Pharmaceutical Corporation Methods for indentifying areas of a subject's skin that appear to lack volume
US8658148B2 (en) * 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
FR2918377B1 (fr) * 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
WO2009012367A1 (en) * 2007-07-18 2009-01-22 Aesthetic Science Composition and method of use for soft tissue augmentation/drug delivery
WO2009018546A1 (en) 2007-08-02 2009-02-05 Medicis Pharmaceutical Corporation Method of applying an injectable filler
US20090204101A1 (en) * 2007-08-20 2009-08-13 Wortzman Mitchell S Method of applying an injectable filler
CN101821294B (zh) 2007-09-28 2012-10-31 株式会社资生堂 溶胀性交联透明质酸粉末及其制造方法
WO2009044403A2 (en) * 2007-10-05 2009-04-09 Juvenis Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
EP2818184B1 (en) 2007-11-16 2018-10-31 Allergan, Inc. Compositions and methods for treating Purpura
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US9687559B2 (en) 2008-03-19 2017-06-27 The Board Of Regents Of The University Of Oklahoma Heparosan polymers and methods of making and using same for the enhancement of therapeutics
US9925209B2 (en) 2008-03-19 2018-03-27 The Board Of Regents Of The University Of Oklahoma Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
GB2459438B (en) * 2008-04-10 2010-10-06 Kythera Biopharmaceuticals Inc Systems and methods for transdermal photo-polymerization
EP2280739B1 (en) * 2008-06-03 2012-07-04 Actamax Surgical Materials LLC A tissue coating for preventing undesired tissue-to-tissue adhesions
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CA2735173C (en) 2008-09-02 2017-01-10 Tautona Group Lp Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
CN101445566B (zh) * 2008-12-11 2011-05-04 彭秀兰 No增放剂精氨酸氨基多糖及其生产方法
US9173975B2 (en) 2009-04-24 2015-11-03 Ingeneron, Inc. Reparative cell delivery via hyaluronic acid vehicles
IT1395392B1 (it) 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
US8273725B2 (en) 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
NZ599524A (en) 2009-11-09 2014-04-30 Spotlight Technology Partners Llc Polysaccharide based hydrogels
CN102695501A (zh) 2009-11-09 2012-09-26 聚光灯技术合伙有限责任公司 碎裂水凝胶
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
KR101764451B1 (ko) 2010-03-12 2017-08-02 알러간 인더스트리 에스에이에스 피부 상태 개선을 위한 히알루론안 폴리머 및 만니톨을 포함하는 유체 조성물
WO2011119468A1 (en) 2010-03-22 2011-09-29 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US9200084B2 (en) * 2010-06-08 2015-12-01 Dow Global Technologies Llc Method for the preparation of a particulate reversibly crosslinked polymeric material
JP2013530785A (ja) 2010-07-12 2013-08-01 シン・プーン・ファーマシューティカル・カンパニー・リミテッド 組織増大用充填組成物
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US20130303695A1 (en) * 2010-09-02 2013-11-14 Heather Sheardown Hyaluronic acid-containing biopolymers
FR2968996B1 (fr) 2010-12-17 2013-04-12 Anteis Sa Formulation aqueuse injectable sterile utilisee en ophtalmologie
EP2484387A1 (en) 2011-02-03 2012-08-08 Q-Med AB Hyaluronic acid composition
EP2691115A1 (en) 2011-03-31 2014-02-05 Galderma Research & Development Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
WO2012146031A1 (zh) * 2011-04-26 2012-11-01 北京爱美客生物科技有限公司 透明质酸与羟丙基甲基纤维素复合凝胶及制备方法
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
CA2838237C (en) 2011-06-03 2020-05-26 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
WO2013016571A1 (en) 2011-07-28 2013-01-31 Harbor Medtech, Inc. Crosslinked human or animal tissue products and their methods of manufacture and use
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
EP2581079B1 (en) * 2011-10-11 2016-12-07 BioPolymer GmbH & Co. KG Combination of hyaluronic acid and prilocaine
ITAN20110138A1 (it) 2011-10-12 2012-01-11 Regenyal Lab S R L Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
WO2013071216A1 (en) * 2011-11-11 2013-05-16 Miba Medical Inc. Injectable filler
AU2013232380A1 (en) 2012-03-12 2014-09-25 The Regents Of The University Of California Methods and compositions for treating wounds and reducing the risk of incisional hernias
KR101240518B1 (ko) 2012-03-26 2013-03-11 주식회사 제네웰 생체 적합성 고분자를 이용한 이식용 재료
EP2831237B1 (en) 2012-03-30 2017-11-29 The Board of Regents of the University of Oklahoma High molecular weight heparosan polymers and methods of production and use thereof
CN102614111B (zh) * 2012-04-05 2013-11-06 苏州豫源生物医药有限公司 氨基葡萄糖的凝胶剂及其制备方法
ITMI20120732A1 (it) 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
ITPD20120173A1 (it) 2012-05-31 2013-12-01 Fidia Farmaceutici "nuovo sistema di rilascio di proteine idrofobiche"
US9822223B2 (en) 2012-06-15 2017-11-21 Merz Pharma Gmbh & Co. Kgaa Method of preparing a composition based on hyaluronic acid
JP5840107B2 (ja) 2012-06-17 2016-01-06 コスメディ製薬株式会社 ヒアルロン酸ゲル及びその製造方法
RU2015133465A (ru) 2013-01-11 2017-02-16 Карбилан Терапьютикс, Инк. Стабилизированные композиции, содержащие гиалуроновую кислоту
CN103146003A (zh) * 2013-03-06 2013-06-12 上海其胜生物制剂有限公司 一种低温二次交联透明质酸钠凝胶的制备方法
KR101869988B1 (ko) * 2013-03-27 2018-06-21 주식회사 엘지화학 점탄성 히알루론산 가교물 제조용 조성물, 및 이를 이용하여 얻은 히알루론산 가교물
CN105555296A (zh) 2013-05-15 2016-05-04 小利兰·斯坦福大学托管委员会 用于鼓膜愈合的肝素结合表皮生长因子活性的调节
WO2014198406A1 (en) 2013-06-11 2014-12-18 Anteis S.A. Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel
US10077320B2 (en) * 2013-06-28 2018-09-18 Galderma S.A. Process for preparing a cross-linked hyaluronic acid product
EP3013865B1 (en) * 2013-06-28 2019-10-23 Galderma S.A. Method for manufacturing a shaped cross-linked hyaluronic acid product
WO2015002091A1 (ja) 2013-07-03 2015-01-08 株式会社リタファーマ 水溶性ヒアルロン酸ゲル及びその製造方法
EP3052529B1 (en) 2013-09-30 2017-10-04 Galderma S.A. Single-step functionalization and cross-linking of hyaluronic acid
KR101459070B1 (ko) 2013-12-09 2014-11-17 (주) 뉴메딕 지속성을 갖는 히알루론산 겔 조성물
AR099900A1 (es) 2014-04-01 2016-08-24 Merz Pharma Gmbh & Co Kgaa Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso
EP3149051A1 (en) * 2014-05-29 2017-04-05 Galderma S.A. Cross-linked polymer mixture of hyaluronic acid and dextran grafted with cyclodextrins and uses thereof
CN106661133A (zh) * 2014-05-29 2017-05-10 盖尔德玛公司 与右旋糖酐接枝的交联的透明质酸
EP3194452B1 (en) 2014-08-29 2018-06-13 Galderma S.A. Enantiopure or enantioenriched bdde and its use as crosslinking agent in the manufacture of cross-linked products
US10722444B2 (en) 2014-09-30 2020-07-28 Allergan Industrie, Sas Stable hydrogel compositions including additives
EP3204017A4 (en) * 2014-10-08 2018-06-27 Andreas Voigt Micronized hydrophilic cross-linked biopolymer systems and method of making same
US10533061B2 (en) 2014-12-18 2020-01-14 Galderma S.A. Grafting of cyclodextrin by amide bonds to an ether cross-linked hyaluronic acid and uses thereof
EP3040117A1 (en) 2014-12-29 2016-07-06 Galderma S.A. Ether cross-linked chondroitin sulfate hydrogels and their use for soft tissue applications
EP3040118A1 (en) 2014-12-29 2016-07-06 Galderma S.A. Ether cross-linked chondroitin hydrogels and their use for soft tissue applications
EP3040348A1 (en) 2014-12-29 2016-07-06 Galderma S.A. Graft copolymer
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
JP7274817B2 (ja) 2015-02-13 2023-05-17 アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエ 顎先等の顔面の容貌を造形し、拡張し、または補正するためのインプラント
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
WO2016192760A1 (en) 2015-05-29 2016-12-08 Galderma S.A. Mixed hydrogels of hyaluronic acid and dextran
EP3307237A1 (en) 2015-06-12 2018-04-18 Laboratoire Français du Fractionnement et des Biotechnologies Injectable composition of factor vii and fillers
FR3037797B1 (fr) 2015-06-24 2018-08-17 Kylane Laboratoires Sa Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
US9737395B2 (en) 2015-06-26 2017-08-22 Phi Nguyen Systems and methods for reducing scarring
EP3316911B1 (en) 2015-06-30 2020-11-04 Merz Pharma GmbH & Co. KGaA Method of preparing a composition based on hyaluronic acid
KR20170025778A (ko) 2015-08-31 2017-03-08 대화제약 주식회사 항산화제를 포함하는 생체 적합성 고분자 히알루론산 유도체 및 그 히알루론산의 가교결합물
KR101720426B1 (ko) 2015-09-01 2017-04-14 (주)시지바이오 히알루론산 조성물 및 그의 제조방법
CN105126157B (zh) * 2015-09-17 2018-02-09 爱美客技术发展股份有限公司 医用可注射粘合凝胶及其制备方法
FR3044557B1 (fr) 2015-12-07 2017-12-01 Benedicte Vincente Gavard Molliard Tauzin Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
FR3047666A1 (fr) 2016-02-15 2017-08-18 Benedicte Vincente Gavard Molliard Tauzin Composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
KR101866310B1 (ko) 2016-05-31 2018-06-11 주식회사 글랜젠 생체 내 지속성 및 항산화 작용이 향상된 진피 충전재 조성물 및 이의 제조방법
WO2017220622A1 (en) 2016-06-23 2017-12-28 Galderma S.A. Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof
HUE050368T2 (hu) 2016-08-03 2020-11-30 Galderma Res & Dev Eljárás glükózaminoglikánok elõállítására
MX2019003206A (es) 2016-09-21 2019-09-18 Nestle Skin Health Sa Gel de acido hialuronico con un cation de zinc divalente.
AR110125A1 (es) 2016-11-07 2019-02-27 Croma Pharma Ges M B H Compuestos poliméricos que liberan sulfuro de hidrógeno
EP3494145B1 (en) 2016-12-23 2020-05-20 Galderma Research & Development Method of crosslinking glycosaminoglycans
EP3494146A1 (en) 2016-12-23 2019-06-12 Galderma Research & Development Double crosslinked glycosaminoglycans
EP3562468A1 (en) 2016-12-29 2019-11-06 Nestlé Skin Health SA Micro- or nanoparticular multilamellar vesicles, compositions comprising the same and method for their use in skin care
EP3562470A1 (en) 2016-12-29 2019-11-06 Nestlé Skin Health SA Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis
EP3562469A1 (en) 2016-12-29 2019-11-06 Nestlé Skin Health SA Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
IT201700008651A1 (it) 2017-01-26 2018-07-26 Beauty System Pharma Ltd Acido ialuronico reticolato con agenti reticolanti di tipo naturale o semisintetico
CN108721206B (zh) * 2017-04-14 2021-11-09 常州药物研究所有限公司 治疗膀胱输尿管返流、压力性尿失禁和大便失禁的组合物及其制备方法
WO2018220283A1 (fr) 2017-05-29 2018-12-06 Kh Medtech Sarl Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine
WO2019002371A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa GLYCOSAMINOGLYCAN GEL WITH BIS-TRIS BUFFER
WO2019001784A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa HYALURONIC ACID GEL WITH A DIVALENT CATION
WO2019121694A1 (en) 2017-12-22 2019-06-27 Nestlé Skin Health Sa Injectable compositions of cross-linked hyaluronic acid and bupivacaine, and uses thereof
AU2019263122B2 (en) 2018-05-03 2022-09-29 Collplant Ltd. Dermal fillers and applications thereof
TWI708607B (zh) 2018-07-06 2020-11-01 南韓商Lg化學股份有限公司 同時具有高度黏彈性和內聚性之玻尿酸填料
RS65307B1 (sr) 2018-07-10 2024-04-30 Lg Chemical Ltd Hijaluronski filer sa velikim kapacitetom liftinga i malom silom ubrizgavanja
KR20200046649A (ko) 2018-10-25 2020-05-07 (주)뉴크레이티브랩 혼합상 히알루론산 제조방법
WO2020130684A1 (ko) 2018-12-20 2020-06-25 주식회사 엘지화학 우수한 필러 특성을 갖는 히알루론산 하이드로겔을 포함하는 필러
KR102398680B1 (ko) 2018-12-21 2022-05-16 주식회사 엘지화학 우수한 필링 특성을 갖는 히알루론산 하이드로겔을 포함하는 필러
ES2969884T3 (es) 2019-04-02 2024-05-23 Volumina Medical Sa Composición que comprende un poliol reticulado
TR201922945A2 (tr) * 2019-12-31 2021-07-26 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Osteoartri̇t tedavi̇si̇ i̇çi̇n propoli̇s i̇çeri̇kli̇ yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇
US12102731B2 (en) 2020-05-01 2024-10-01 Harbor Medtech, Inc. Port-accessible multidirectional reinforced minimally invasive collagen device for soft tissue repair
KR102425496B1 (ko) 2020-05-08 2022-07-26 주식회사 종근당 고탄성, 고점도 및 고유효 가교율을 갖는 히알루론산 가교체, 및 이의 제조방법
US20240269349A1 (en) 2021-09-09 2024-08-15 Sunbio Inc. Sol-gel conversion over time of 6-arm peg hydrogel
IT202100032111A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Nuovi sostituti biocompatibili dell’umor vitreo
WO2023148619A1 (en) 2022-02-01 2023-08-10 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
US12312447B2 (en) 2023-06-19 2025-05-27 Zhejiang Triple Win New Material Co., Ltd. Preparation method for polysaccharide spherical gel resin
WO2025086125A1 (en) 2023-10-25 2025-05-01 L'oreal Composition for conditioning keratin fibers

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197846A (en) * 1974-10-09 1980-04-15 Louis Bucalo Method for structure for situating in a living body agents for treating the body
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
GB8412423D0 (en) * 1984-05-16 1984-06-20 Allied Colloids Ltd Polymeric compositions
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
SE458525B (sv) * 1985-05-23 1989-04-10 Pharmacia Ab Foerfarande foer tvaerbindning av en poroes agar- eller agarosgel
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4767463A (en) * 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5017229A (en) * 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5007940A (en) * 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2158638C (en) * 1993-03-19 1999-11-30 Bengt Agerup A composition and a method for tissue augmentation

Also Published As

Publication number Publication date
EP0839159A1 (en) 1998-05-06
ATE204000T1 (de) 2001-08-15
HUP9901714A2 (hu) 1999-09-28
TR199800072T1 (xx) 1998-05-21
CA2226488A1 (en) 1997-02-06
PL324608A1 (en) 1998-06-08
JPH11509256A (ja) 1999-08-17
DE69614391D1 (de) 2001-09-13
CA2226488C (en) 2005-12-06
KR100314488B1 (ko) 2001-12-28
PT839159E (pt) 2001-11-30
SK282431B6 (sk) 2002-02-05
NO980213D0 (no) 1998-01-16
JP3094074B2 (ja) 2000-10-03
ES2161368T3 (es) 2001-12-01
PL188071B1 (pl) 2004-12-31
SI0839159T1 (en) 2002-04-30
CZ12998A3 (cs) 1998-06-17
NO980213L (no) 1998-03-16
MX9800484A (es) 1998-04-30
UA48980C2 (ru) 2002-09-16
WO1997004012A1 (en) 1997-02-06
DE839159T1 (de) 1999-10-07
CN1083849C (zh) 2002-05-01
NO315274B1 (no) 2003-08-11
HU220257B (hu) 2001-11-28
BRPI9609534B8 (pt) 2020-05-12
HUP9901714A3 (en) 2000-06-28
CN1190974A (zh) 1998-08-19
SK6198A3 (en) 1999-01-11
GR3037065T3 (en) 2002-01-31
BR9609534B1 (pt) 2010-07-27
NZ312229A (en) 1998-11-25
AU6371896A (en) 1997-02-18
KR19990029034A (ko) 1999-04-15
EA001500B1 (ru) 2001-04-23
DK0839159T3 (da) 2001-10-08
EP0839159B1 (en) 2001-08-08
DE69614391T2 (de) 2002-02-14
US5827937A (en) 1998-10-27
CZ290755B6 (cs) 2002-10-16
BR9609534A (pt) 1999-02-23
AU700215B2 (en) 1998-12-24

Similar Documents

Publication Publication Date Title
EA199800133A1 (ru) Способ получения композиции поперечно-сшитого биологического полисахаридного геля, композиция и её применение
DK0862418T3 (da) Fremgangsmåde til fremstilling af morphologisk ensartede mikrokapsler såvel som mikrokapsler fremstillet efter denne fremgangsmåde
DE3750793D1 (de) Verfahren zur Behandlung von Kollagen zur Erleichterung seiner Vernetzung und das so erhaltene Kollagen.
DK0892815T3 (da) Fremgangsmåde til fremstilling af en porøs tværbundet polysaccharidgel og dennes anvendelse som gelfiltreringsmedium og ved chromatografi
DK0466300T3 (da) Bioforligelige viskoelastiske gel-opslæmninger, deres fremstilling og anvendelse
DE122009000058I1 (de) Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
FR2861734B1 (fr) Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
FI901330A0 (fi) Menetelmä veteen liukenemattomien hyaluronihappogeelien ja -kalvojen valmistamiseksi
FI932626A0 (fi) Av en patogenisk aemne haerledande antigenisk polysackarid deriverad oligosackarid
ES2032121T3 (es) Particulas de emulsion gelificadas y composiciones que las contienen.
ATE445648T1 (de) Verfahren zur herstellung von chitosan
RU94010864A (ru) Способ получения инсулинсодержащих полимерных гидрогелей
DE3868898D1 (de) Feuerfeste verglasung und verfahren zur herstellung.
ATE286869T1 (de) Verfahren zur herstellung eines diols
NO954858L (no) Fremgangsmåte for fremstilling av en biodegraderbar, hydrofobisk og transparent film og film oppnådd ved fremgangsmåten
KR920004399A (ko) 결정성 taca의 제조방법
GB1375035A (ru)
US4087487A (en) Carriers for biologically active compounds and methods for the production thereof
US3969436A (en) Carriers for biologically active compounds and methods for the production thereof
ATE123763T1 (de) Verfahren zur herstellung von 3- aminocrotonnitril.
RU96102085A (ru) Сорбент для удаления атерогенных липопротеидов из крови и способ его получения
KR930016476A (ko) 친수성의 약염기성 음이온 교환수지의 제조방법
KR910005780A (ko) 유자와 과당(설탕)을 가미시킨 멸치 젖국의 제조방법
JPS565138A (en) Water absorbing agent
KR950000191A (ko) 크로마토그래피용 분리제의 제조방법

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM

MK4A Patent expired

Designated state(s): BY KZ RU